{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:49:18Z","timestamp":1793040558679,"version":"4.5.0"},"reference-count":90,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ultragenyx Pharmaceutical (United States)","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Glycogen storage disease type Ia (GSDIa) is caused by defective glucose-6-phosphatase, a key enzyme in carbohydrate metabolism. Affected individuals cannot release glucose during fasting and accumulate excess glycogen and fat in the liver and kidney, putting them at risk of severe hypoglycaemia and secondary metabolic perturbations. Good glycaemic\/metabolic control through strict dietary treatment and regular doses of uncooked cornstarch (UCCS) is essential for preventing hypoglycaemia and long-term complications. Dietary treatment has improved the prognosis for patients with GSDIa; however, the disease itself, its management and monitoring have significant physical, psychological and psychosocial burden on individuals and parents\/caregivers. Hypoglycaemia risk persists if a single dose of UCCS is delayed\/missed or in cases of gastrointestinal intolerance. UCCS therapy is imprecise, does not treat the cause of disease, may trigger secondary metabolic manifestations and may not prevent long-term complications. We review the importance of and challenges associated with achieving good glycaemic\/metabolic control in individuals with GSDIa and how this should be balanced with age-specific psychosocial development towards independence, management of anxiety and preservation of quality of life (QoL). The unmet need for treatment strategies that address the cause of disease, restore glucose homeostasis, reduce the risk of hypoglycaemia\/secondary metabolic perturbations and improve QoL is also discussed.<\/jats:p>","DOI":"10.3390\/nu13113828","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T23:24:42Z","timestamp":1635377082000},"page":"3828","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7259-1095","authenticated-orcid":false,"given":"Terry G. J.","family":"Derks","sequence":"first","affiliation":[{"name":"Division of Metabolic Diseases, Beatrix Children\u2019s Hospital, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Rodriguez-Buritica","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Medical Genetics, McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth Houston) and Children\u2019s Memorial Hermann Hospital, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Genetics, Metabolism and Genomic Medicine, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foekje","family":"de Boer","sequence":"additional","affiliation":[{"name":"Division of Metabolic Diseases, Beatrix Children\u2019s Hospital, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4861-9905","authenticated-orcid":false,"given":"Mar\u00eda L.","family":"Couce","sequence":"additional","affiliation":[{"name":"IDIS, CIBERER, MetabERN, University Clinical Hospital of Santiago de Compostela, 15706 Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-0468","authenticated-orcid":false,"given":"Sarah C.","family":"Gr\u00fcnert","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics, Adolescent Medicine and Neonatology, Faculty of Medicine, Medical Center-University of Freiburg, 79106 Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Labrune","sequence":"additional","affiliation":[{"name":"APHP, Universit\u00e9 Paris-Saclay, H\u00f4pital Antoine-B\u00e9cl\u00e8re, 92140 Clamart, France"},{"name":"Inserm U 1195, Paris-Saclay University, 94276 Le Kremlin Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4730-7750","authenticated-orcid":false,"given":"Nerea","family":"L\u00f3pez Maldonado","sequence":"additional","affiliation":[{"name":"Piera Health Center, Catalan Institute of Health, 08007 Barcelona, Spain"},{"name":"Autonomous University of Barcelona, 08193 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Fischinger Moura de Souza","sequence":"additional","affiliation":[{"name":"Medical Genetics Service, HCPA, Porto Alegre 90035-903, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Riba-Wolman","sequence":"additional","affiliation":[{"name":"Connecticut Children\u2019s Medical Center, Department of Pediatrics, Division of Endocrinology, University of Connecticut, Farmington, CT 06032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1689-4948","authenticated-orcid":false,"given":"Alessandro","family":"Rossi","sequence":"additional","affiliation":[{"name":"Division of Metabolic Diseases, Beatrix Children\u2019s Hospital, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands"},{"name":"Department of Translational Medicine, Section of Paediatrics, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1169-7072","authenticated-orcid":false,"given":"Heather","family":"Saavedra","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Medical Genetics, McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth Houston) and Children\u2019s Memorial Hermann Hospital, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupal Naik","family":"Gupta","sequence":"additional","affiliation":[{"name":"Ultragenyx Pharmaceutical Inc., Novato, CA 94949, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassili","family":"Valayannopoulos","sequence":"additional","affiliation":[{"name":"Ultragenyx Pharmaceutical Inc., Novato, CA 94949, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Endocrinology, Montreal Children\u2019s Hospital, McGill University Health Center, Montreal, QC H4A 3J1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1172-6-27","article-title":"Glucose-6-phosphatase deficiency","volume":"6","author":"Froissart","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_2","unstructured":"Sperling, M.A. (2008). Hypoglycemia in neonates and infants. Pediatric Endocrinology, W.B. Saunders. [3rd ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0022-3476(74)80342-2","article-title":"Comparison of the effects of total parenteral nutrition, continuous intragastric feeding, and portacaval shunt on a patient with type I glycogen storage disease","volume":"85","author":"Burr","year":"1974","journal-title":"J. Pediatr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM197602192940805","article-title":"Continuous Nocturnal Intragastric Feeding for Management of Type 1 Glycogen-Storage Disease","volume":"294","author":"Greene","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1203\/00006450-198409000-00015","article-title":"The Dietary Treatment of Children with Type I Glycogen Storage Disease with Slow Release Carbohydrate","volume":"18","author":"Smit","year":"1984","journal-title":"Pediatr. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1183\/16000617.0017-2016","article-title":"Why we should care about ultra-rare disease","volume":"25","author":"Harari","year":"2016","journal-title":"Eur. Respir. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/qjmed\/hci128","article-title":"Drugs for exceptionally rare diseases: Do they deserve special status for funding?","volume":"98","author":"Hughes","year":"2005","journal-title":"Qjm: Int. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.8211187","article-title":"Mutations in the Glucose-6-Phosphatase Gene that Cause Glycogen Storage Disease Type 1a","volume":"262","author":"Lei","year":"1993","journal-title":"Science"},{"key":"ref_9","unstructured":"National Organization for Rare Disorders (NORD) (2021, August 13). Glycogen Storage Disease Type I. Available online: https:\/\/rarediseases.org\/rare-diseases\/glycogen-storage-disease-type-i\/."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10545-014-9772-x","article-title":"Type I glycogen storage diseases: Disorders of the glucose-6-phosphatase\/glucose-6-phosphate transporter complexes","volume":"38","author":"Chou","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_11","first-page":"45","article-title":"Glycogen storage diseases: Diagnosis, treatment and outcome","volume":"1","author":"Chen","year":"2016","journal-title":"Transl. Sci. Rare Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.pcl.2017.11.005","article-title":"Inborn Errors of Metabolism with Hypoglycemia: Glycogen storage diseases and inherited disorders of gluconeogenesis","volume":"65","author":"Weinstein","year":"2018","journal-title":"Pediatr. Clin. N. Am."},{"key":"ref_13","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Mirzaa, G., and Amemiya, A. (1993). Glycogen Storage Disease Type I. GeneReviews(R), University of Washington."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/humu.21327","article-title":"Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases","volume":"31","author":"Scott","year":"2010","journal-title":"Hum. Mutat."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12108","DOI":"10.1074\/jbc.275.16.12108","article-title":"Differential Role of Hepatocyte Nuclear Factor-1 in the Regulation of Glucose-6-phosphatase Catalytic Subunit Gene Transcription by cAMP in Liver- and Kidney-derived Cell Lines","volume":"275","author":"Streeper","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_16","unstructured":"Parikh, N.S., and Ahlawat, R. (2021). Glycogen Storage Disease Type I. StatPearls, StatPearls Publishing."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jimd.12380","article-title":"Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia","volume":"44","author":"Hoogerland","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"27030","DOI":"10.1074\/jbc.M704144200","article-title":"11\u03b2-Hydroxysteroid Dehydrogenase Type 1 Regulation by Intracellular Glucose 6-Phosphate Provides Evidence for a Novel Link between Glucose Metabolism and Hypothalamo-Pituitary-Adrenal Axis Function","volume":"282","author":"Walker","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13023-020-01377-w","article-title":"Imbalanced cortisol concentrations in glycogen storage disease type I: Evidence for a possible link between endocrine regulation and metabolic derangement","volume":"15","author":"Rossi","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_20","first-page":"S20","article-title":"Glycogen storage disease type I: Diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I)","volume":"161","author":"Rake","year":"2002","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3748\/wjg.v13.i18.2541","article-title":"Glycogen Storage Diseases: New Perspectives","volume":"13","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_22","unstructured":"UpToDate\u00ae (2021, August 13). Glucose-6-Phosphatase Deficiency (Glycogen Storage Disease I, von Gierke Disease). Available online: https:\/\/www.uptodate.com\/contents\/glucose-6-phosphatase-deficiency-glycogen-storage-disease-i-von-gierke-disease."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nrendo.2010.189","article-title":"Glycogen storage disease type I and G6Pase-\u03b2 deficiency: Etiology and therapy","volume":"6","author":"Chou","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: A practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet. Med."},{"key":"ref_25","first-page":"S112","article-title":"Guidelines for management of glycogen storage disease type I\u2014European Study on Glycogen Storage Disease Type I (ESGSD I)","volume":"161","author":"Labrune","year":"2002","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/GIM.0b013e3181e655b6","article-title":"Glycogen Storage Disease Type III diagnosis and management guidelines","volume":"12","author":"Kishnani","year":"2010","journal-title":"Genet. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jpeds.2011.02.031","article-title":"Natural History of Hepatocellular Adenoma Formation in Glycogen Storage Disease Type I","volume":"159","author":"Wang","year":"2011","journal-title":"J. Pediatr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10545-012-9490-1","article-title":"Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study","volume":"36","author":"Sechi","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/JPN.0000000000000017","article-title":"Pregnancy in Women With Glycogen Storage Disease Ia and Ib","volume":"28","author":"Ferrecchia","year":"2014","journal-title":"J. P\u00e9rinat. Neonatal Nurs."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/MPG.0000000000000592","article-title":"Inflammatory Bowel Disease in Glycogen Storage Disease Type Ia","volume":"64","author":"Lawrence","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/gim.2012.41","article-title":"Characterization and pathogenesis of anemia in glycogen storage disease type Ia and Ib","volume":"14","author":"Wang","year":"2012","journal-title":"Genet. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Jacoby, J.T., dos Santos, B.B., Nalin, T., Colonetti, K., Refosco, L.F., de Souza, C.F.M., Spritzer, P.M., Poloni, S., Hack-Mendes, R., and Schwartz, I.V.D. (2021). Bone Mineral Density in Patients with Hepatic Glycogen Storage Diseases. Nutrients, 13.","DOI":"10.3390\/nu13092987"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10545-017-0039-1","article-title":"Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: The added value of CUSUM for metabolic control","volume":"40","author":"Peeks","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jhep.2010.03.002","article-title":"An adult male patient with multiple adenomas and a hepatocellular carcinoma: Mild Glycogen Storage Disease type Ia","volume":"53","author":"Cassiman","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/hep.29858","article-title":"Glycogen storage disease type Ia: Adult presentation with microcytic anemia and liver adenomas","volume":"68","author":"Moest","year":"2018","journal-title":"Hepatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e22644","DOI":"10.1097\/MD.0000000000022644","article-title":"A case report of acute pancreatitis with glycogen storage disease type IA in an adult patient and review of the literature","volume":"99","author":"Ai","year":"2020","journal-title":"Medicine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1074\/jbc.M110486200","article-title":"The Molecular Basis of Glycogen Storage Disease Type 1a: Structure and function analysis of mutations in glucose-6-phosphatase","volume":"277","author":"Shieh","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1440-1746.1999.01914.x","article-title":"Case report: Hepatocellular carcinoma in type 1a glycogen storage disease with identification of a glucose-6-phosphatase gene mutation in one family","volume":"14","author":"Nakamura","year":"2002","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1007\/BF02679989","article-title":"Glycogen storage disease type I: Diagnosis and phenotype\/genotype correlation","volume":"161","author":"Matern","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1203\/00006450-200009000-00011","article-title":"Glucose-6-Phosphatase Mutation G188R Confers an Atypical Glycogen Storage Disease Type 1b Phenotype","volume":"48","author":"Weston","year":"2000","journal-title":"Pediatr. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/jpepsy\/jsn017","article-title":"Psychosocial Functioning in Youth with Glycogen Storage Disease Type I","volume":"33","author":"Storch","year":"2008","journal-title":"J. Pediatr. Psychol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1093\/hmg\/ddz133","article-title":"Gene therapy for glycogen storage diseases","volume":"28","author":"Kishnani","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_43","first-page":"687","article-title":"The effect of portacaval transposition on carbohydrate metabolism: Experimental and clinical observations","volume":"57","author":"Starzl","year":"1965","journal-title":"Surgery"},{"key":"ref_44","first-page":"100655","article-title":"Enteral tube feeding in patients receiving dietary treatment for metabolic diseases: A retrospective analysis in a large French cohort","volume":"26","author":"Roda","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0140-6736(78)92187-6","article-title":"Hypoglyc\u00e6mia complicating feeding regimens for glycogen-storage disease","volume":"312","author":"Leonard","year":"1978","journal-title":"Lancet"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/adc.72.3.274-b","article-title":"Hypoglycaemia complicating treatment regimens for glycogen storage disease","volume":"72","author":"Dunger","year":"1995","journal-title":"Arch. Dis. Child."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2013.02.005","article-title":"Dietary treatment of glycogen storage disease type Ia: Uncooked cornstarch and\/or continuous nocturnal gastric drip-feeding?","volume":"109","author":"Derks","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Ross, K.M., Ferrecchia, I.A., Dahlberg, K.R., Dambska, M., Ryan, P.T., and Weinstein, A.D. (2019). Dietary Management of the Glycogen Storage Diseases: Evolution of Treatment and Ongoing Controversies. Adv. Nutr.","DOI":"10.1093\/advances\/nmz092"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jimd.12160","article-title":"Cornstarch requirements of the adult glycogen storage disease Ia population: A retrospective review","volume":"43","author":"Dahlberg","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s10545-007-0479-0","article-title":"A novel starch for the treatment of glycogen storage diseases","volume":"30","author":"Bhattacharya","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3945\/ajcn.2008.26352","article-title":"Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib","volume":"88","author":"Correia","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/8904_2015_488","article-title":"Safety and Efficacy of Chronic Extended Release Cornstarch Therapy for Glycogen Storage Disease Type I","volume":"26","author":"Ross","year":"2015","journal-title":"JIMD Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10545-014-9763-y","article-title":"In vitro digestion of starches in a dynamic gastrointestinal model: An innovative study to optimize dietary management of patients with hepatic glycogen storage diseases","volume":"38","author":"Nalin","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Monteiro, V.C.L., de Oliveira, B.M., dos Santos, B.B., Sperb-Ludwig, F., Refosco, L.F., Nalin, T., Derks, T.G.J., de Souza, C.F.M., and Schwartz, I.V.D. (2021). A triple-blinded crossover study to evaluate the short-term safety of sweet manioc starch for the treatment of glycogen storage disease type Ia. Orphanet J. Rare Dis., 16.","DOI":"10.1186\/s13023-021-01877-3"},{"key":"ref_55","unstructured":"Mathew, T.K., and Tadi, P. (2021). Blood Glucose Monitoring. StatPearls, StatPearls Publishing."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/jimd.12383","article-title":"A retrospective in-depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: Recommended outcome parameters for glucose management","volume":"44","author":"Peeks","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1651-2227.1974.tb16992.x","article-title":"The effect of disaccharides on the hyperlactacidaemia of glucose-6-phosphatase-deficient children","volume":"63","author":"Fernandes","year":"1974","journal-title":"Acta Paediatr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jcsm.12383","article-title":"GLIM criteria for the diagnosis of malnutrition\u2014A consensus report from the global clinical nutrition community","volume":"10","author":"Cederholm","year":"2019","journal-title":"J. Cachex Sarcopenia Muscle"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Colonetti, K., Dos Santos, B.B., Nalin, T., De Souza, C.F.M., Triplett, E.W., Dobbler, P.C.T., Schwartz, I.V.D., and Roesch, L.F.W. (2019). Hepatic glycogen storage diseases are associated to microbial dysbiosis. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0218254"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1749-6632.2010.05820.x","article-title":"Neuroendocrine responses to hypoglycemia","volume":"1212","author":"Tesfaye","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10545-018-0200-5","article-title":"Role of continuous glucose monitoring in the management of glycogen storage disorders","volume":"41","author":"Herbert","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_62","unstructured":"US Food & Drug Administration (2021, August 13). Patient Listening Summaries: Glycogen Storage Disease (GSD) Type 1, Available online: https:\/\/www.fda.gov\/patients\/learn-about-fda-patient-engagement\/patient-listening-session-summaries."},{"key":"ref_63","first-page":"130056","article-title":"Continuous glucose monitoring in the treatment of obesity in patients with glycogen storage disease type Ia","volume":"2014","author":"Jelaska","year":"2014","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/8904_2014_359","article-title":"Disordered Eating and Body Esteem Among Individuals with Glycogen Storage Disease","volume":"19","author":"Flanagan","year":"2014","journal-title":"JIMD Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0140-6736(82)90257-4","article-title":"Lactate as energy source for brain in glucose-6-phosphatase deficient child","volume":"319","author":"Fernandes","year":"1982","journal-title":"Lancet"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ejcn.2013.186","article-title":"Continuous glucose monitoring in children with glycogen storage disease type I","volume":"68","author":"Kasapkara","year":"2013","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ymgme.2019.02.008","article-title":"Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry","volume":"126","author":"Kaiser","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1002\/dmrr.518","article-title":"Continuous glucose monitoring in conditions other than diabetes","volume":"20","author":"Maran","year":"2004","journal-title":"Diabetes\/Metab. Res. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10545-011-9335-3","article-title":"The use of continuous glucose monitoring in the practical management of glycogen storage disorders","volume":"34","author":"White","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-015-0301-2","article-title":"Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: Possible role of microsomal glucose 6-phosphate accumulation","volume":"10","author":"Melis","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/gim.2012.36","article-title":"Bone mineral density in glycogen storage disease type Ia and Ib","volume":"14","author":"Minarich","year":"2012","journal-title":"Genet. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"F442","DOI":"10.1152\/ajprenal.1992.262.3.F442","article-title":"Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro","volume":"262","author":"Krieger","year":"1992","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/jimd.12386","article-title":"A generic emergency protocol for patients with inborn errors of metabolism causing fasting intolerance: A retrospective, single-center study and the generation of www.emergencyprotocol.net","volume":"44","author":"Rossi","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/8904_2013_283","article-title":"Quality of Life in Adult Patients with Glycogen Storage Disease Type I: Results of a Multicenter Italian Study","volume":"14","author":"Sechi","year":"2013","journal-title":"JIMD Rep."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Venema, A., Peeks, F., der Veen, M.d.B.-v., de Boer, F., Fokkert-Wilts, M.J., Lubout, C.M.A., Huskens, B., Dumont, E., Mulkens, S., and Derks, T.G.J. (2021). A retrospective study of eating and psychosocial problems in patients with hepatic glycogen storage diseases and idiopathic ketotic hypoglycemia: Towards a standard set of patient-reported outcome measures. JIMD Rep., in press.","DOI":"10.1002\/jmd2.12253"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-021-02006-w","article-title":"Impact of glycogen storage disease type I on adult daily life: A survey","volume":"16","author":"Garbade","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_78","unstructured":"Nemours (2021, September 22). Children\u2019s Health System. Surgeries and Procedures: Gastrostomy Tube (G-Tube)., Available online: https:\/\/kidshealth.org\/Nemours\/en\/parents\/gastrostomy.html."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Butler, J., Dress, A., Theodore-Oklota, C., Egan, S., Paulich, M., Byrd, C., and Evans, C. (2020, January 18\u201320). The Humanistic Burden of Glycogen Storage Disease Type IA\u2014The Impact on Symptoms, Diet and Health-Related Quality of Life. Proceedings of the Virtual ISPOR 2020, Orlando, FL, USA.","DOI":"10.1016\/j.jval.2020.04.1292"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/8904_2018_131","article-title":"Feeding Difficulties and Orofacial Myofunctional Disorder in Patients with Hepatic Glycogen Storage Diseases","volume":"45","author":"Martinez","year":"2018","journal-title":"JIMD Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/2251-6581-12-25","article-title":"Glycogen Storage Disease type 1a\u2014A secondary cause for hyperlipidemia: Report of five cases","volume":"12","author":"Carvalho","year":"2013","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1172-9-47","article-title":"Liver transplantation in glycogen storage disease type I","volume":"9","author":"Boers","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2326409816649599","article-title":"Orthotopic Liver Transplantation in Glycogen Storage Disease Type 1a","volume":"4","author":"Wilke","year":"2016","journal-title":"J. Inborn Errors Metab. Screen."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01.tp.0000231689.44266.ac","article-title":"Human Hepatocyte Transplantation: Worldwide Results","volume":"82","author":"Fisher","year":"2006","journal-title":"Transplantation"},{"key":"ref_85","first-page":"469","article-title":"Liver and liver cell transplantation for glycogen storage disease type IA","volume":"68","author":"Muraca","year":"2006","journal-title":"Acta Gastro-Enterol. Belg."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/petr.12741","article-title":"Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management","volume":"20","author":"Oishi","year":"2016","journal-title":"Pediatr. Transplant."},{"key":"ref_87","unstructured":"Rodriguez-Buritica, D.F., Ahmad, A., Couce Pico, M.L., Derks, T.G., Mitchell, J., Riba-Wolman, R., Mou, J., Poma, A., Valayannopoulos, V., and Crombez, E. (2021, January 12\u201315). AAV8-Mediated Liver-Directed Gene Therapy as a Potential Therapeutic Option in Adults with Glycogen Storage Disease Type Ia (GSDIa): Updated Phase 1\/2 Clinical Trial Results. Proceedings of the American Society of Gene + Cell Therapy, Portland, OR, USA."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e20170108","DOI":"10.1542\/peds.2017-0108","article-title":"The Care Continuum: An Evolving Model for Care and Research in Rare Diseases","volume":"140","author":"Augustine","year":"2017","journal-title":"Pediatrics"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jimd.12178","article-title":"Research priorities for liver glycogen storage disease: An international priority setting partnership with the James Lind Alliance","volume":"43","author":"Peeks","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/dme.14286","article-title":"A standard set of person-centred outcomes for diabetes mellitus: Results of an international and unified approach","volume":"37","author":"Nano","year":"2020","journal-title":"Diabet. Med."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/11\/3828\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:21:18Z","timestamp":1760167278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/11\/3828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":90,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["nu13113828"],"URL":"https:\/\/doi.org\/10.3390\/nu13113828","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]}}}